Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Blum

Showing results (211-220 of 291) with videos related to

Pageof 30
Sort By:
Epilepsia|July 2, 2019
Serum sodium levels and related treatment-emergent adverse events during eslicarbazepine acetate use in adults with epilepsyRobert T Wechsler, Rodney A Radtke, Michael Smith, et al.
Clinical and Translational Radiation Oncology|June 12, 2023
Mortality during or shortly after curative-intent radio-(chemo-) therapy over the last decade at a large comprehensive cancer centerSebastian M Christ, Jonas Willmann, Philip Heesen, et al.
Biochemical Society Transactions|March 21, 2014
From epidemiology to pathophysiology: what about caffeine in Alzheimer's disease?Vanessa Flaten, Cyril Laurent, Joana E Coelho, et al.
Bioengineering & Translational Medicine|January 23, 2023
Neuroprotective activity of a virus-safe nanofiltered human platelet lysate depleted of extracellular vesicles in Parkinson's disease and traumatic brain injury modelsLiling Delila, Ouada Nebie, Nhi Thao Ngoc Le, et al.
Epilepsy & Behavior : E&B|November 18, 2015
Severity and burden of partial-onset seizures in a phase III trial of eslicarbazepine acetateJoyce A Cramer, Fulton F Velez, Kathryn P Anastassopoulos, et al.
Nutrients|March 28, 2024
Daily Caffeine Consumption May Increase the Risk of Acute Kidney Injury Related to Platinum-Salt Chemotherapy in Thoracic Cancer Patients: A Translational StudyAghiles Hamroun, Antoine Decaestecker, Romain Larrue, et al.
ACS Chemical Neuroscience|May 8, 2026
A Proline-Rich-Domain-Binding Single Domain Antibody Selectively Inhibits RNA-Induced Phase Separation of TauSimon Thiou, Leslie Martin, Evangelia Manousaki, et al.
European Journal of Medicinal Chemistry|October 30, 2015
Design and synthesis of fused tetrahydroisoquinoline-iminoimidazolinesValeria Moas-Héloire, Nicolas Renault, Vania Batalha, et al.
Acta Neuropathologica Communications|May 7, 2025
Temporal transcriptomic changes in the THY-Tau22 mouse model of tauopathy display cell type- and sex-specific differencesMuhammad Ali, Pierre Garcia, Laetitia P Lunkes, et al.
Epilepsy & Behavior : E&B|June 3, 2017
Adjunctive eslicarbazepine acetate: A pooled analysis of three phase III trialsVictor Biton, Joanne B Rogin, Gregory Krauss, et al.
Pageof 30

Showing results (211-220 of 291) with videos related to

Sort By:
Pageof 30
Epilepsia|July 2, 2019
Serum sodium levels and related treatment-emergent adverse events during eslicarbazepine acetate use in adults with epilepsyRobert T Wechsler, Rodney A Radtke, Michael Smith, et al.
Clinical and Translational Radiation Oncology|June 12, 2023
Mortality during or shortly after curative-intent radio-(chemo-) therapy over the last decade at a large comprehensive cancer centerSebastian M Christ, Jonas Willmann, Philip Heesen, et al.
Biochemical Society Transactions|March 21, 2014
From epidemiology to pathophysiology: what about caffeine in Alzheimer's disease?Vanessa Flaten, Cyril Laurent, Joana E Coelho, et al.
Bioengineering & Translational Medicine|January 23, 2023
Neuroprotective activity of a virus-safe nanofiltered human platelet lysate depleted of extracellular vesicles in Parkinson's disease and traumatic brain injury modelsLiling Delila, Ouada Nebie, Nhi Thao Ngoc Le, et al.
Epilepsy & Behavior : E&B|November 18, 2015
Severity and burden of partial-onset seizures in a phase III trial of eslicarbazepine acetateJoyce A Cramer, Fulton F Velez, Kathryn P Anastassopoulos, et al.
Nutrients|March 28, 2024
Daily Caffeine Consumption May Increase the Risk of Acute Kidney Injury Related to Platinum-Salt Chemotherapy in Thoracic Cancer Patients: A Translational StudyAghiles Hamroun, Antoine Decaestecker, Romain Larrue, et al.
ACS Chemical Neuroscience|May 8, 2026
A Proline-Rich-Domain-Binding Single Domain Antibody Selectively Inhibits RNA-Induced Phase Separation of TauSimon Thiou, Leslie Martin, Evangelia Manousaki, et al.
European Journal of Medicinal Chemistry|October 30, 2015
Design and synthesis of fused tetrahydroisoquinoline-iminoimidazolinesValeria Moas-Héloire, Nicolas Renault, Vania Batalha, et al.
Acta Neuropathologica Communications|May 7, 2025
Temporal transcriptomic changes in the THY-Tau22 mouse model of tauopathy display cell type- and sex-specific differencesMuhammad Ali, Pierre Garcia, Laetitia P Lunkes, et al.
Epilepsy & Behavior : E&B|June 3, 2017
Adjunctive eslicarbazepine acetate: A pooled analysis of three phase III trialsVictor Biton, Joanne B Rogin, Gregory Krauss, et al.
Pageof 30